BRISTOL MYERS SHARES UP 3.7% PREMARKET AFTER CO'S CANCER THERAPY MEETS MAIN GOAL IN LATE-STAGE STUDY, LUNG DRUG SHOWS BENEFIT IN TRIAL

Reuters · 4d ago

Please log in to view news